Syntax Research’s Arvinas ARVN Stock Holding History

Syntax Research’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-200	Closed	-$3.93K	–	177
2023 Q3	$3.93K	Buy	+200	New	+$4.91K	﹤0.01%	163

Other funds holding ARVN

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Syntax Research's ARVN Position: Q4 2023 in Review

Syntax Research sold out of Arvinas (ARVN) in Q4 2023, closing a stake of 200 shares — an estimated $3.93K sold.

Syntax Research first reported a position in ARVN in Q3 2023 and held it in 1 quarter. The position peaked at $3.93K in Q3 2023. 212 funds tracked by Wall St. Rank hold ARVN as of Q4 2023.

Syntax Research reported no remaining Arvinas position as of Q4 2023 after selling out during the quarter.
Syntax Research sold 200 Arvinas shares in Q4 2023, an estimated $3.93K.
Syntax Research first reported a position in Arvinas in Q3 2023 and held it in 1 quarter.
Syntax Research's Arvinas position peaked at $3.93K in Q3 2023.
212 funds tracked by Wall St. Rank held Arvinas as of Q4 2023.

Based on Syntax Research's 13F filing for Q4 2023, filed 30 Jan 2024.